Lloveras Josep, Arcos Emma, Comas Jordi, Crespo Marta, Pascual Julio
1 Department of Nephrology, Hospital del Mar, Passeig Maritim, Barcelona, Spain. 2 Catalan Renal Registry, Catalan Transplant Organization, Health Department, Generalitat of Catalonia, Passeig Taulat, Barcelona, Spain.
Transplantation. 2015 May;99(5):991-6. doi: 10.1097/TP.0000000000000474.
Kidney transplantation from deceased donors aged 65 years or older is associated with suboptimal patient and graft survival. In large registries, survival is longer after kidney transplantation than when remaining on dialysis. However, whether recipients of these old grafts survive longer than their dialysis counterparts is unknown.
We retrospectively assessed the outcomes of 5,230 recipients of first deceased donor grafts transplanted during the period of 1990 to 2010 in Catalonia, 915 of whom received grafts from donors 65 years or older. In a match-pair analysis, we aimed to pair each of 915 eligible cases with one control (1:1 ratio). Each pair had the same characteristics at the time of entering dialysis program: age, sex, primary renal disease, period of dialysis onset, and cardiovascular comorbidities. We found 823 pairs.
Patient survival of 823 recipients of elderly donors was significantly higher than that of their 823 matched dialysis waitlisted nontransplanted partners (91.6%, 74.5%, and 55.5% vs. 88.8%, 44.2%, and 18.1%, respectively at 1, 5, and 10 years; P<0.001). The probability of death after the first year was similar (8.1% transplant vs 10.3% dialysis; P=0.137); however, analyzing the whole period, the adjusted proportional risk of death was 2.66 (95% confidence interval, 2.21-3.20) times higher for patients remaining on dialysis than for transplanted patients (P<0.001).
Our study demonstrates that despite the fact that kidney transplantation from elderly deceased donors is associated with reduced graft and patient survival, their paired counterpart patients remaining on dialysis have a risk of death 2.66 times higher.
接受65岁及以上已故供体的肾脏移植与患者及移植物的生存效果欠佳相关。在大型登记处,肾脏移植后的生存期比继续接受透析的时间更长。然而,这些老年供体肾脏移植受者的生存期是否长于接受透析的同龄人尚不清楚。
我们回顾性评估了1990年至2010年期间在加泰罗尼亚接受首例已故供体肾脏移植的5230例受者的结局,其中915例接受了65岁及以上供体的肾脏移植。在配对分析中,我们旨在将915例符合条件的病例与一名对照(1:1比例)进行配对。每对在进入透析项目时具有相同的特征:年龄、性别、原发性肾病、透析开始时间和心血管合并症。我们找到了823对。
823例接受老年供体肾脏移植受者的患者生存率显著高于其823名配对的等待透析但未移植的对照者(1年、5年和10年时分别为91.6%、74.5%和55.5%,而对照者分别为88.8%、44.2%和18.1%;P<0.001)。第一年之后的死亡概率相似(移植组为8.1%,透析组为10.3%;P=0.137);然而,分析整个时间段,继续接受透析的患者调整后的死亡比例风险比移植患者高2.66倍(95%置信区间,2.21-3.20)(P<0.001)。
我们的研究表明,尽管接受老年已故供体的肾脏移植与移植物及患者生存率降低相关,但其配对的继续接受透析的对照患者的死亡风险高出2.66倍。